Certara Biotech Forum London: Building an Investor-Ready Strategy and Story Live Events Certara Biotech Forum London: Building an Investor-Ready Strategy and Story –CertaraOctober 19, 2026
2nd Model-Informed Drug Development Summit Conference 2nd Model-Informed Drug Development Summit –sarah CarrOctober 13, 2026
From Data to Decisions: Getting More from Clinical Trial Evidence Webinar From Data to Decisions: Getting More from Clinical Trial Evidence Matt Zierhut, PhD MBAOctober 13, 2026
Drug-Drug Interaction (DDI) Calculator Fact Sheet Drug-Drug Interaction (DDI) Calculator The DDI Calculator within the Drug Interaction Database (DIDB) is a tool designed to quantitatively…CertaraOctober 8, 2026
Population Pharmacokinetics of Dolutegravir in Plasma and Cerebrospinal Fluid in Adults Living With HIV Publication Population Pharmacokinetics of Dolutegravir in Plasma and Cerebrospinal Fluid in Adults Living With HIV Explore population PK modeling of dolutegravir in plasma and cerebrospinal fluid to characterize CNS penetration…CertaraOctober 5, 2026
Simultaneous Population PKPD Analysis of Belantamab Mafodotin, Soluble BCMA, and Serum M-Protein in Relapsed/Refractory Multiple Myeloma Publication Simultaneous Population PKPD Analysis of Belantamab Mafodotin, Soluble BCMA, and Serum M-Protein in Relapsed/Refractory Multiple Myeloma Explore a simultaneous population PK/PD model characterizing the dynamic relationships between belantamab mafodotin, sBCMA, and…CertaraOctober 5, 2026
2nd TCE for Autoimmune Disease Summit Conference 2nd TCE for Autoimmune Disease Summit –Danielle PillsburyOctober 5, 2026
Model-Informed Strategies for ADC Development White Paper Model-Informed Strategies for ADC Development Explore how model informed drug development can help ADC developers optimize dosing, reduce uncertainty, strengthen…Danielle PillsburySeptember 22, 2026
When EV Dose Is Not What It Seems: Quantitative Mismatch Between Particle Number- and Protein-Based Dosing Publication When EV Dose Is Not What It Seems: Quantitative Mismatch Between Particle Number- and Protein-Based Dosing Research shows that particle- and protein-based extracellular vesicle dosing are not interchangeable, supporting a multidimensional…CertaraSeptember 18, 2026
Pharmacometric Analysis of Givinostat to Support Individualized Dosing Recommendations in Pediatric Patients with Duchenne Muscular Dystrophy Poster Pharmacometric Analysis of Givinostat to Support Individualized Dosing Recommendations in Pediatric Patients with Duchenne Muscular Dystrophy Pharmacometric modeling of givinostat in pediatric DMD supported a simplified 4-band weight-based dosing regimen without…CertaraSeptember 14, 2026